Physician profile
Charles Hopkins Crawford
NPI 1265570808
$836,095.91
in general payments reported to CMS, 2019-2025
13 companies · $241K in 2025
The $241K reported for 2025 was more than what 97% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57K · 2020: $47K · 2021: $92K · 2022: $79K · 2023: $150K · 2024: $170K · 2025: $241K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $381K · Consulting Fee: $119K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $29K · Travel and Lodging: $26K · Food and Beverage: $6,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $380,974.57 |
| Consulting Fee | $118,736.79 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $29,465.00 |
| Travel and Lodging | $25,767.50 |
| Food and Beverage | $6,152.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $375,977.56 | 2021-2025 | Infinity Occipitocervical Upper Thoracic System, Infuse Bone Graft, Cd Horizon Spinal System |
| Nuvasive, INC. | $179,183.81 | 2019-2023 | Modulus, Pulse, Tlif |
| Globus Medical, INC. | $143,802.14 | 2024-2025 | Modulus, Modulus, Alif |
| Alphatec Spine, INC | $59,303.84 | 2019-2025 | Arsenal Deformity, Arsenal Degenerative, Invictus Open |
| Medtronic USA, INC. | $54,174.98 | 2019-2020 | |
| Expanding Innovations, INC. | $19,054.40 | 2024-2025 | X-Pac |
| Si-Bone, INC. | $3,621.22 | 2020-2025 | |
| Stryker Corporation | $435.67 | 2021-2023 | |
| Ebi, LLC | $145.70 | 2025 | |
| Medacta USA, INC. | $124.99 | 2019 | |
| Bioventus LLC | $115.38 | 2022 | |
| Depuy Synthes Sales INC. | $95.09 | 2023 | Acf |
| Surgalign Spine Technologies, INC. | $61.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$38,493.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Crawford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.